Discounted Cash Flow (DCF) Analysis Levered
Mesa Laboratories, Inc. (MLAB)
$196.14
+5.50 (+2.89%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 96.18 | 103.13 | 117.69 | 133.94 | 58.88 | 55.80 | 52.89 | 50.13 | 47.51 | 45.03 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | 24.81 | 30.55 | 26.56 | 37.07 | 39.22 | 19.23 | 18.22 | 17.27 | 16.37 | 15.52 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -2.80 | -1.26 | -1.50 | -1.99 | -4.43 | -1.61 | -1.53 | -1.45 | -1.37 | -1.30 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | 22.01 | 29.29 | 25.06 | 35.08 | 34.79 | 17.62 | 16.70 | 15.83 | 15 | 14.22 |
Weighted Average Cost Of Capital
Share price | $ 196.14 |
---|---|
Beta | 0.525 |
Diluted Shares Outstanding | 5.33 |
Cost of Debt | |
Tax Rate | -3,778.26 |
After-tax Cost of Debt | 2.29% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 5.325 |
Total Debt | 169.37 |
Total Equity | 1,046.41 |
Total Capital | 1,215.77 |
Debt Weighting | 13.93 |
Equity Weighting | 86.07 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 96.18 | 103.13 | 117.69 | 133.94 | 58.88 | 55.80 | 52.89 | 50.13 | 47.51 | 45.03 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | 24.81 | 30.55 | 26.56 | 37.07 | 39.22 | 19.23 | 18.22 | 17.27 | 16.37 | 15.52 |
Capital Expenditure | -2.80 | -1.26 | -1.50 | -1.99 | -4.43 | -1.61 | -1.53 | -1.45 | -1.37 | -1.30 |
Free Cash Flow | 22.01 | 29.29 | 25.06 | 35.08 | 34.79 | 17.62 | 16.70 | 15.83 | 15 | 14.22 |
WACC | ||||||||||
PV LFCF | 16.80 | 15.18 | 13.71 | 12.39 | 11.19 | |||||
SUM PV LFCF | 69.26 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 4.90 |
Free cash flow (t + 1) | 14.50 |
Terminal Value | 500.05 |
Present Value of Terminal Value | 393.67 |
Intrinsic Value
Enterprise Value | 462.93 |
---|---|
Net Debt | 120.02 |
Equity Value | 342.91 |
Shares Outstanding | 5.33 |
Equity Value Per Share | 64.28 |